top of page


Data-Driven Trends In Predetermined Change Control Plans
Data-driven trends show increased FDA authorization of PCCPs, enhancing SaMD compliance and postmarket change controls.
Yu Zhao
2024年7月12日読了時間: 9分
閲覧数:1回
0件のコメント


Part III: SaMD PCCP Implementation Beyond AIML: Considerations & Challenges
This article provides tips and practical considerations for PCCP implementation.
Yu Zhao
2023年10月13日読了時間: 6分
閲覧数:3回
0件のコメント


Part I: Medical Device Postmarket Change Controls and FDA 510(k) Software Modification Guidance
FDA's guidance on postmarket change controls for 510(k) software modifications ensures SaMD changes maintain safety and compliance.
Yu Zhao
2023年10月4日読了時間: 5分
閲覧数:1回
0件のコメント

Implementing a PCCP for Class II SaMD Products Beyond AI/ML
This white paper provides a comprehensive analysis of the PCCP,
along with practical insights into implementation priorities and approaches
Yu Zhao
2023年9月12日読了時間: 1分
閲覧数:1回
0件のコメント

Yu Zhao Co-Hosts Panel on Global AI-Based Medical Device Regulations at MedCon 2022
Yu Zhao co-hosted a panel on AI-based medical device regulations at MedCon 2022, discussing EU AI Act and U.S. FDA framework for SaMD.
Yu Zhao
2022年5月3日読了時間: 1分
閲覧数:0回
0件のコメント
bottom of page